PFA

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

Retrieved on: 
Jeudi, mai 9, 2024
PFA, Physics, Safety, Arrhythmia, Catheter ablation, HRS, PVC, MD, Cardiac electrophysiology, Workflow, Mount Sinai Health System, Ventricular tachycardia, Cardiac cycle, Patient, Atrial fibrillation, Boston Scientific, Medical device

CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field Medical,™ Inc., a pioneer in pulsed field cardiac catheter ablation technology, today announced the initiation of its first-in-human study for the FieldForce™ Ablation System at Na Homolce Hospital in Prague, Czech Republic. The Ventricular Catheter Ablation Study, VCAS, will enroll up to 60 patients at up to 5 sites world-wide. The VCAS investigational study is a critical step towards demonstrating safety and performance of the FieldForce™ Ablation System, developed specifically to address the limitations of existing pulsed field ablation (PFA) and radiofrequency (RF) ablation systems, including a more time efficient treatment protocol for the treatment of ventricular arrhythmias. Preliminary results will be presented on May 16, 2024, at the Heart Rhythm Scientific Sessions in Boston, Mass.

Key Points: 
  • First and only contact force pulsed field ablation (PFA) system designed to transform treatment for millions with life-threatening ventricular arrhythmias.
  • CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field Medical,™ Inc., a pioneer in pulsed field cardiac catheter ablation technology, today announced the initiation of its first-in-human study for the FieldForce™ Ablation System at Na Homolce Hospital in Prague, Czech Republic.
  • The Ventricular Catheter Ablation Study, VCAS , will enroll up to 60 patients at up to 5 sites world-wide.
  • Current ventricular catheter ablation methods involve lengthy procedures and significant risks associated with thermal ablation, like conventional RF ablation.

Field Medical Announces First-in-Human Trials for Groundbreaking FieldForce™ Ventricular Pulsed Field Ablation Technology

Retrieved on: 
Jeudi, mai 9, 2024
PFA, Physics, Safety, Arrhythmia, Catheter ablation, HRS, PVC, MD, Cardiac electrophysiology, Workflow, Mount Sinai Health System, Ventricular tachycardia, Cardiac cycle, Patient, Atrial fibrillation, Boston Scientific, Medical device

CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field Medical,™ Inc., a pioneer in pulsed field cardiac catheter ablation technology, today announced the initiation of its first-in-human study for the FieldForce™ Ablation System at Na Homolce Hospital in Prague, Czech Republic. The Ventricular Catheter Ablation Study, VCAS, will enroll up to 60 patients at up to 5 sites world-wide. The VCAS investigational study is a critical step towards demonstrating safety and performance of the FieldForce™ Ablation System, developed specifically to address the limitations of existing pulsed field ablation (PFA) and radiofrequency (RF) ablation systems, including a more time efficient treatment protocol for the treatment of ventricular arrhythmias. Preliminary results will be presented on May 16, 2024, at the Heart Rhythm Scientific Sessions in Boston, Mass.

Key Points: 
  • First and only contact force pulsed field ablation (PFA) system designed to transform treatment for millions with life-threatening ventricular arrhythmias.
  • CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field Medical,™ Inc., a pioneer in pulsed field cardiac catheter ablation technology, today announced the initiation of its first-in-human study for the FieldForce™ Ablation System at Na Homolce Hospital in Prague, Czech Republic.
  • The Ventricular Catheter Ablation Study, VCAS , will enroll up to 60 patients at up to 5 sites world-wide.
  • Current ventricular catheter ablation methods involve lengthy procedures and significant risks associated with thermal ablation, like conventional RF ablation.

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias

Retrieved on: 
Mercredi, mai 8, 2024
Physician, University, PFA, EP, PRA, B cell, University of Pennsylvania, Cleveland Clinic, American Medical Association, St Davids, Patient, Arrhythmia, Multimedia, UCLA Health, Medical Center, Electrophysiology

AUSTIN, Texas, May 8, 2024 /PRNewswire/ -- On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024.

Key Points: 
  • AUSTIN, Texas, May 8, 2024 /PRNewswire/ -- On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024.
  • Participants included practicing clinical cardiac electrophysiologists, electrophysiologist fellows and general cardiologists who have an interest in treating complex cardiac arrhythmias—a condition in which the heart beats with an irregular or abnormal rhythm.
  • The primary teaching tool was live cases with expert commentary broadcast from the Electrophysiology Center at St. David's Medical Center, the leading robotic electrophysiology center in North America.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/texas-cardiac-arrhythmia-instit...
    SOURCE Texas Cardiac Arrhythmia Institute at St. David’s Medical Center

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias

Retrieved on: 
Mercredi, mai 8, 2024
Physician, University, PFA, EP, PRA, B cell, University of Pennsylvania, Cleveland Clinic, American Medical Association, St Davids, Patient, Arrhythmia, UCLA Health, Medical Center, Electrophysiology

AUSTIN, Texas, May 8, 2024 /PRNewswire/ -- On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024.

Key Points: 
  • AUSTIN, Texas, May 8, 2024 /PRNewswire/ -- On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024.
  • Participants included practicing clinical cardiac electrophysiologists, electrophysiologist fellows and general cardiologists who have an interest in treating complex cardiac arrhythmias—a condition in which the heart beats with an irregular or abnormal rhythm.
  • The primary teaching tool was live cases with expert commentary broadcast from the Electrophysiology Center at St. David's Medical Center, the leading robotic electrophysiology center in North America.
  • Physicians received a maximum of 14.5 American Medical Association (AMA) Physician's Recognition Award (PRA) Category 1 Credit™ hours at the conference.

Three PFCs Partner with ePayPolicy on Newest Financing Feature

Retrieved on: 
Mardi, mai 7, 2024
CFPB, AMEX, BNPL, Thought, Reach Out Worldwide, Insurance, PFC, Embarrassment, Generation Z, PFA, Millennials, Connect, Online shopping

AUSTIN, Texas, May 7, 2024 /PRNewswire/ -- Three premium finance companies have partnered with ePayPolicy as part of the ongoing rollout of ePay's newest feature, Finance Connect. US Premium Finance, AFCO Direct and People's Premium Finance announced connections to the platform, in order to enable easier access to premium financing for the insurance industry.

Key Points: 
  • ePay believes more insurance customers will choose "Buy Now, Pay Later" financing with more convenient access to established premium financing companies.
  • AUSTIN, Texas, May 7, 2024 /PRNewswire/ -- Three premium finance companies have partnered with ePayPolicy as part of the ongoing rollout of ePay's newest feature, Finance Connect.
  • "Insurance organizations of all kinds are thinking about ways they can improve the customer experience," said ePayPolicy CEO Mark Engels.
  • Access to financing is vital, and we knew we could work together to improve both the access and the experience."

Imbox Protection Wins Prestigious International Red Dot Award for Innovative Product Design

Retrieved on: 
Jeudi, mai 2, 2024
Water damage, PFA, Shoe, Red, Heat, SNIPES, Aalto, Dillard's, The Red Dot, Famous Footwear, Criterion, Shoemaking

DENMARK, May 2, 2024 /PRNewswire/ -- Imbox Protection , the world's only in-store footwear protection technology, today announced it won the Red Dot Award for Product Design 2024 for its minimalist appearance and innovative approach to automating the care service in shoe stores, relieving the burden on sales staff.

Key Points: 
  • DENMARK, May 2, 2024 /PRNewswire/ -- Imbox Protection , the world's only in-store footwear protection technology, today announced it won the Red Dot Award for Product Design 2024 for its minimalist appearance and innovative approach to automating the care service in shoe stores, relieving the burden on sales staff.
  • The Red Dot Award, one of the most highly regarded seals of design quality worldwide, selects winners via a panel of international experts who seek exceptional design and innovation, composed of 39 experts from 20 countries across four continents.
  • Imbox Protection will be recognized at the Red Dot Gala June 24, 2024, at the Aalto Theatre in Essen, Germany.
  • "We're truly grateful to receive the Red Dot Award for Product Design 2024," shared Oliver Hede, vice president of North American sales at Imbox Protection.

ePayPolicy Partners with US Premium Finance to Make Financing at Checkout Easier for Insurance Industry

Retrieved on: 
Lundi, avril 29, 2024
PFA, USPF, Reach Out Worldwide, CFPB, Insurance, BNPL, History, Online shopping

NORCROSS, Ga., April 29, 2024 /PRNewswire/ -- ePayPolicy has partnered with US Premium Finance to make their premium financing solutions for insurance companies easier to access for the industry.

Key Points: 
  • NORCROSS, Ga., April 29, 2024 /PRNewswire/ -- ePayPolicy has partnered with US Premium Finance to make their premium financing solutions for insurance companies easier to access for the industry.
  • With ePayPolicy's latest feature release, Finance Connect , US Premium Finance can now offer the same level of convenience when paying premiums online.
  • "Central to the creation of Finance Connect was our intent to preserve existing partnerships with PFCs," added Mark Engels, ePayPolicy CEO.
  • ePayPolicy is integrated with over 90% of the most popular agency management systems, saving time and manual data entry

Canada’s Industry Leaders Unite to Tackle Plastic Waste with Launch of Unnecessary & Problematic Plastics Guidance

Retrieved on: 
Mercredi, avril 24, 2024
PFAS, Nature, PFA, CPP, Animal, Partnership, Waste management, Plastic, Ellen, Elimination, Recycling, Chair

OTTAWA, April 24, 2024 (GLOBE NEWSWIRE) -- The Canada Plastics Pact (CPP), in partnership with the National Zero Waste Council, has released guidance for industry to take urgent measures to eliminate unnecessary and problematic plastics. The guidance includes a list of 13 unnecessary or problematic items and flagged four in transition as industries collaborate to scale solutions.

Key Points: 
  • OTTAWA, April 24, 2024 (GLOBE NEWSWIRE) -- The Canada Plastics Pact (CPP), in partnership with the National Zero Waste Council, has released guidance for industry to take urgent measures to eliminate unnecessary and problematic plastics.
  • The guidance includes a list of 13 unnecessary or problematic items and flagged four in transition as industries collaborate to scale solutions.
  • The CPP recognizes that relying solely on recycling systems will not solve our plastic packaging waste challenges, and that even if industry were to meet all recycling targets it would not be sufficient to eliminate plastic waste entirely.
  • To read the Elimination of Unnecessary & Problematic Plastics Guidance, please click here .

Middlesex Water Has Implemented Its Strategy for Compliance With New More Stringent Federal Regulations for PFAS

Retrieved on: 
Jeudi, avril 11, 2024
MCL, PFAS, PFOA, EPA, Investment, Perfluorinated compound, PFOS, Food packaging, Carbon, PPT, PFA, Middlesex Water Company, Cosmetics

The Company begun implementing its strategy in 2023 in anticipation to the new EPA regulation.

Key Points: 
  • The Company begun implementing its strategy in 2023 in anticipation to the new EPA regulation.
  • PFAS are a group of widely used chemicals, used in industry and consumer products like non-stick cookware and food packaging since the 1940s.
  • This new federal MCL for PFOS and PFOA is lower than the New Jersey standard of 14 ppt established in 2021.
  • “It should be noted that water utilities do not produce PFAS chemicals but bring cost effective and innovative solutions to meet all state and federal safe drinking compliance requirements,” added Leslie.

Parsons to Support Clients in Addressing PFAS and Achieving EPA’s National PFAS Drinking Water Regulations

Retrieved on: 
Jeudi, avril 11, 2024
PFAS, EPA, Drinking water, Research, Water, PSN, Groundwater, Soil, PFA, Parsons Corporation, Cosmetics

CHANTILLY, Va., April 11, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN), an industry leading Per and Polyfluoroalkyl Substances (PFAS) investigation and remediation company, is ready to support our current and future clients in addressing PFAS and achieving the U.S. Environmental Protection Agency’s (EPA) first-ever national regulations for PFAS in drinking water.

Key Points: 
  • CHANTILLY, Va., April 11, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN), an industry leading Per and Polyfluoroalkyl Substances (PFAS) investigation and remediation company, is ready to support our current and future clients in addressing PFAS and achieving the U.S. Environmental Protection Agency’s (EPA) first-ever national regulations for PFAS in drinking water.
  • Parsons has advised clients around the world on PFAS investigation and remediation challenges for more than 15 years.
  • “As a leading PFAS services provider, Parsons understands the EPA’s focus on reducing chemicals in our drinking water and stands ready to support our clients in assessing and addressing their PFAS challenges,” said Dan Griffiths, Parsons’ Vice President and PFAS Practice Director.
  • “Parsons has completed nearly 2,000 PFAS investigations for industrial, commercial, and federal clients, and designed and installed over 7,000 PFAS point of entry treatment systems, in addition to building large full scale water treatment plants to remove PFAS from drinking water and wastewater.